Treatment of drug-resistant epilepsy with vagus nerve stimulation — review of 45 cases
Chinese Medical Journal, 12/21/2011Min B et al.
Vagus nerve stimulation (VNS) is a safe and effective treatment for drug–resistant epilepsy (DRE). Duration of VNS therapy may be a crucial factor on prognosis.
The authors retrospectively examined 45 cases of DRE that received VNS treatment in the center from June 2004 to June 2010 and analyzed the parameters (age of patient receiving VNS, seizure frequency before and after VNS as well as treatment duration) by Student’s t test, Fisher’s exact and Mann–Whitney U tests, and multivariate Logistic regression.
The overall response rate was 64% (29/45), 67% (6/9) for adults and 64% (23/36) for children, with no significant difference (P=0.28).
Twenty–two cases had been in VNS therapy for over 1 year with a treatment efficacy of 73% (16/22), whereas 23 cases had been in VNS therapy no more than 1 year with a treatment effecacy of 57% (13/23), and has statistically significant difference (P=0.03).
The main side effect included hoarseness of voice and cough.
One patient’s device was removed due to infection.
One patient’s VNS was half–way terminated due to seizure aggravation.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.